USPTO serial 88695562
ILD-PRO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 14, 2020
- Examiner
- FIONDA,LAURA ELIZABETH
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ILD-PRO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $850
Owner
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, CT
Other trademarks owned by Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, CT
Other trademarks owned by Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, CT
Other trademarks owned by Boehringer Ingelheim Pharmaceuticals, Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott J. Major
Scott J. Major MILLEN WHITE ZELANO & BRANIGAN, PC2200 CLARENDON BLVD., 14TH FLOORARLINGTON, VA 22201United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Maintaining registries of patients with interstitial lung diseases; promoting awareness of interstitial lung diseases, their symptoms, prevention and treatment, and promoting awareness of biomarker testing therefor | ACTIVE | Jan 15, 2019 |
| 044 | Providing medical and pharmaceutical information regarding interstitial lung diseases, their symptoms, prevention and treatment, and providing medical information regarding biomarker testing relating thereto | ACTIVE | Jan 15, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Boehringer Ingelheim Pharmaceuticals, Inc.
- Other trademarks owned by Boehringer Ingelheim Pharmaceuticals, Inc.
- Other trademarks owned by Boehringer Ingelheim Pharmaceuticals, Inc.
- Other trademarks in Class 035
- Other trademarks in Class 044
- Similar marks named ILD-PRO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 8, 2026 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jan 8, 2026 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jan 8, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 1, 2025 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Jul 14, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jul 14, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 28, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 28, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 8, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 23, 2020 | ALIE | ASSIGNED TO LIE | — |
| Mar 14, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 10, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 9, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 9, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 25, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 25, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 25, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 13, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 22, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 20, 2019 | NWAP | NEW APPLICATION ENTERED | — |